At a glance commentaryScientific background on the subjectThe ICU physician care volume may affect ICU pneumonia patient\'s mortality. The difference between physician\'s high and low care volume may also impact on the outcome of ICU severe septic patients.What this study adds to the fieldWe proved that ICU care by high care volume physicians may be better than that by low care volume physicians in patients with severe sepsis. The benefit provided by high care volume may relate to higher complete rate of bundle therapy.

Severe sepsis or septic shock are a lethal critical illness resulting in multiple organ dysfunction and high overall hospital mortality rate of 17.9--50.0% in different populations [@bib1], [@bib2]. The complicated physical states in patients with severe sepsis frequently require intensive and critical care, which leads to high intensive care unit (ICU) admissions [@bib3]. Such patients remain a major challenge in modern medicine. The "Surviving Sepsis Campaign (SSC)" guidelines provide evidence-based recommendations for managing patients with sepsis and improving their outcomes [@bib4], [@bib5]. But while better medical treatment can alter a patient\'s outcome, more extensive considerations should not only focus on medical treatment. An ever-increasing number of discussions about ICU care models and physician staffing has also been mentioned.

A study by Reynolds et al. concluded that critical care medicine (CCM) physicians may decrease mortality of ICU patients with septic shock [@bib6]. A study by Brown et al. had similar results, showing that a full-time, trained critical care specialist may reduce ICU morbidity and mortality [@bib7]. A systemic review demonstrated that high intensity ICU physician staffing is associated with a reduction in ICU mortality and length of stay [@bib8]. In their study, the high intensity care group was mandatory intensivist consultation, or all-care directed by the intensivist. Now, it is generally accepted that the care model managed by a trained CCM physician leading a multi-disciplinary team improves the outcome of ICU patients [@bib9].

Most medical ICUs in Taiwan are staffed with full-time CCM physicians to be qualified by hospital accreditation. However, these CCM physicians may not be permanently located in ICU to be an ICU physician. In Taiwan, a pulmonologist is trained to not only be a pulmonary specialist but also a CCM specialist. The pulmonologist can join the ICU team to be a full-time CCM physician, also called an intensivist, or simply manage patients with pulmonary disease in the wards. Therefore, patients may be treated by high ICU care volume physician with more experience in critical care or by low ICU care volume physician with less experience in critical care. From a analysis of Taiwan\'s National Health Insurance, physician\'s care volume significantly predicted inpatient mortality in ICU pneumonia patients [@bib10]. Since the ICU physician care volume may affect ICU pneumonia patient\'s mortality, the difference between physician\'s high and low care volume may also impact on the outcome of ICU severe septic patients. We analyzed the data from a three-year prospective observation study to examine whether physicians with higher care volume offer ICU severe septic patients better outcomes.

Materials and methods {#sec1}
=====================

Subjects {#sec1.1}
--------

From July 2007 to June 2010, we carried out an observational research program "analyzing the key treatments to increase the survival of the patients with severe sepsis". This study enrolled patients with severe sepsis who were admitted to the medical ICU of Chang Gung Memorial Hospital-Keelung (CGMH-Keelung) during the three years. Severe sepsis was defined as sepsis with organ dysfunction, hypo-perfusion, or hypotension [@bib11]. The medical ICU at CGMH-Keelung is a 10-bed closed unit staffed with a full-time ICU physician who is a qualified pulmonary and CCM specialist. Eight physicians rotated in ICU care monthly during the three years when this full-time ICU physician was off or rotated to the general ward. If a patient was admitted to one physician and cared by another physician later, this patient was classified to the physician who cared these patients for more time during the first 3 days of admission. Repeated admission to ICU was set as a new admission and that subject had the same age, gender and medical history. High and low care volumes are defined according to Lin\'s study from a analysis of Taiwan\'s National Health Insurance [@bib10].

This study recorded the following clinical data: age, gender, medical history, infection source, Acute Physiology and Chronic Health Evaluation (APACHE) II score, co-morbidity, and treatments in the first three days of ICU admission. The recorded treatments were the standard bundle therapies used to manage sepsis according to SSC guidelines [@bib4]. These bundle therapies included fluid resuscitation (normal saline or hydroxyethyl starch), broad spectrum antibiotics, use of low-dose steroids in septic shock, use of activated protein C (APC), adequate blood transfusion, sedation/paralysis, blood glucose control, renal replacement therapy as needed, stress ulcer prophylaxis, and basic support. Fluid resuscitation was administered with either crystalloid or colloid infusion to maintain central venous pressure between 8 and 12 mmHg. APC was given for septic patients with an APACHE II score \>25 and without contraindications. An adequate hemoglobin maintenance was red blood cell (RBC) transfusion for hemoglobin \<7.0 mg/dl to target 7.0--9.0 mg/dl. All of the treatments were based on the ICU patient\'s condition and physician\'s decision without any intervention by data collectors. Survivors were defined as the patients alive after 28 days of ICU admission. The data collected from this observational study were divided into fixed and rotated groups to compare the survival of these two different ICU care strategies. Because this research program was an observational study without any intervention and patient\'s identification, the hospital\'s Institutional Review Board at Chang Gung Memorial Hospital (IRB/CGMH, No. 98-1682C) approved this study without need of informed consent from the patients or the patient\'s family.

Statistical analysis {#sec1.2}
--------------------

Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS) V11.0.1 for Windows (SPSS Inc., Chicago, USA). Differences in continuous variables between the two groups were analyzed by the T-test while those in categorical variables were compared using the Chi--Square test, as appropriate. Univariate and multivariate Cox proportional-hazards model was performed using methods of enter and forward stepwise to compare survival with histories, APACHE II score, co-morbidities, and physician\'s care volume. Survival curves after adjustment were constructed. A p value \<0.05 was considered statistically significant.

Results {#sec2}
=======

Information of physicians was shown in [Table 1](#tbl1){ref-type="table"}. The clinical characteristics of patients with severe sepsis were shown in [Table 2](#tbl2){ref-type="table"}. During the 3 years, physician 6 cared 298 severe septic patients and the other 186 patients were cared by other 7 physicians. Between survivors and non-survivors, there were no significant differences in gender, sources of sepsis, and physician\'s care volume. However, non-survivors had higher APACHE II scores and higher percentages of liver cirrhosis and co-morbidities. Non-survivors had lower age and lower percentages of hypertension, diabetes mellitus, and old cerebral vascular accident (CVA).Table 1Physician characteristics and care volume in 3 years.Table 1PatientsAgeYears out of trainingNumber of weekly outpatient service in the ICU monthPhysician 11847163Physician 23150163Physician 34246143Physician 4385093Physician 5324173Physician 62984063Physician 7133553Physician 8123643[^1]Table 2Clinical characteristics (number \[percentage\] and mean ± standard error mean) between survivors and non-survivors with severe sepsis.Table 2Survivors (n = 320)Non-survivors (n = 164)Gender Male200 (62.5)100 (61.0) Female120 (37.5)64 (39.0)Age, year73.93 ± 0.8071.01 ± 1.12[a](#tbl2fna){ref-type="table-fn"}History Chronic obstructive pulmonary disease62 (19.4)27 (16.5) Heart failure37 (11.6)12 (7.3) Hypertension160 (50.0)52 (31.7)[a](#tbl2fna){ref-type="table-fn"} Liver cirrhosis19 (5.9)24 (14.6)[a](#tbl2fna){ref-type="table-fn"} Diabetes mellitus113 (35.3)43 (26.2)[a](#tbl2fna){ref-type="table-fn"} End stage renal disease32 (10.0)21 (12.8) Old cerebral vascular accident108 (33.8)22 (13.4)[a](#tbl2fna){ref-type="table-fn"}APACHE II score24.07 ± 0.4129.96 ± 0.63[a](#tbl2fna){ref-type="table-fn"}Source of sepsis Pneumonia251 (78.4)128 (78.0) Urinary tract infection37 (11.6)9 (5.5) Others32 (10.0)27 (16.5)Co-morbidity Shock96 (30.0)119 (72.6)[a](#tbl2fna){ref-type="table-fn"} Respiratory failure283 (88.4)156 (95.1)[a](#tbl2fna){ref-type="table-fn"} Acute renal failure117 (36.6)90 (54.9)[a](#tbl2fna){ref-type="table-fn"} Jaundice20 (6.3)26 (15.9)[a](#tbl2fna){ref-type="table-fn"} Thrombocytopenia80 (25.0)93 (56.7)[a](#tbl2fna){ref-type="table-fn"} Gastrointestinal bleeding34 (10.6)41 (25.0)[a](#tbl2fna){ref-type="table-fn"} Bacteremia37 (11.6)32 (19.5)[a](#tbl2fna){ref-type="table-fn"}Physician\'s care volume High199 (62.2)99 (60.4) Low121 (37.8)65 (39.6)[^2][^3]

Results of the Cox regression analysis to determine independent factors for patient mortality were shown in [Table 3](#tbl3){ref-type="table"}. High physician\'s care volume and old CVA were independent factors related to decreased mortality. Shock, respiratory failure, thrombocytopenia, and gastrointestinal (GI) bleeding were independent factor increasing the risk of the mortality. Age, hypertension, liver cirrhosis, diabetes mellitus, APACHE II score, acute renal failure, jaundice and bacteremia were not independent factors affecting mortality.Table 3Univariate and multivariate Cox regression analysis to determine independent factors of patient\'s mortality.Table 3VariablesUnivariate analysisMultivariate analysisHR95% CI*p* valueHR95% CI*p* valueAge0.9970.986--1.0080.599Hypertension0.7660.541--1.0860.135Liver cirrhosis0.9480.562--1.6000.841Diabetes mellitus0.8230.571--1.1860.295Old CVA0.5390.336--0.8640.0100.4780.302--0.7560.002APACHE II score1.0521.030--1.075\<0.001Shock3.0042.065--4.370\<0.0013.8592.716--5.483\<0.001Respiratory failure1.7920.859--3.7380.1202.7471.344--5.6120.006Acute renal failure1.1480.822--1.6040.418Jaundice1.2620.764--2.0840.363Thrombocytopenia1.8351.301--2.5900.0012.0851.514--2.872\<0.001Gastrointestinal bleeding1.5321.058--2.2190.0241.6711.163--2.3990.005Bacteremia0.8160.538--1.2370.339High physician\'s care volume0.6270.448--0.8780.0070.7080.514--0.9740.034[^4]

Bundle therapy information on sepsis between high and low care volume groups was shown in [Table 4](#tbl4){ref-type="table"}. There was no significant difference in fluid resuscitation, efficacy of antibiotics treatment, patient sedation, and use of APC. Seventy-six patients in low volume group and 138 in high volume group had septic shock. There was an 88% administration of low-dose steroid for septic shock in high care volume group, which was significantly higher than the 68.4% administration in low volume group. There was also a significantly higher percentage of adequate blood transfusion strategy in low care volume group than that in high care volume group (96.2% vs. 89.6%).Table 4Bundle therapies in patients with high and low care volume.Table 4VariableHighLow*p* valueFluid resuscitation on the day of ICU admission, ml[a](#tbl4fna){ref-type="table-fn"}1658.361839.050.18Initial antibiotics treatment, no./total no. (%)0.389 Culture sensitive138/298 (46.3)83/186 (44.6) Culture resistant91/298 (30.5)67/186 (36.0) Clinical improve69/298 (23.2)36/186 (19.4)Use of low dose steroid in septic shock, no./total no. (%)\<0.001 Use122/138 (88.4)52/76 (68.4) No use16/138 (11.6)24/76 (31.6)APC use in APACHE II ≥ 25, no./total no. (%)0.06 Use2/179 (1.1)4/82 (4.9) No use177/179 (98.9)78/82 (95.1)Adequate maintenance of hematocrit/hemoglobin, no./total no. (%)0.008 Yes267/298 (89.6)179/186 (96.2) No31/298 (10.4)7/186 (3.8)Sedation, no./total no. (%)0.341 Use72/298 (24.2)38/186 (20.4) No use226/298 (75.8)148/186 (79.6)Glucose control in patients with available data, no./total no. (%)0.016 \<150 mg/dl100/293 (34.1)46/181 (25.4) 150--200 mg/dl130/293 (44.4)76/181 (42.0) \>200 mg/dl63/293 (21.5)59/181 (32.6)Renal replacement therapy in acute renal failure, no./total no. (%)0.028 HD16/126 (12.7)5/73 (6.8) CVVHD33/126 (26.2)10/73 (13.7) No use77/126 (61.1)58/73 (79.5)Prophylactic treatment for GI bleeding, no./total no. (%)\<0.001 PPI93/298 (31.2)65/186 (34.9) H2 blocker20/298 (6.7)47/186 (25.3) Sucralfate9/298 (3.0)0/186 (0) MgO164/298 (55.1)24/186 (12.9) No use12/298 (4.0)50/186 (26.9)[^5][^6]

There were 181 patients and 293 patients who needed hyperglycemic control in the low and high care volume groups, respectively. Compared with low care volume group, higher percentage of patients with hyperglycemia was in less than 200 mg/dl in high care volume group. There were 73 patients cared for by low care volume physicians who developed acute renal failure within the first three days of ICU admission. Fifteen of them (20.5%) received renal replacement therapy either by hemodialysis or continuous veno-venous hemodialysis (CVVHD). In high care volume group, there was a higher percentage (38.9%) of receiving renal replacement therapy in the initial three days of ICU admission in acute renal failure patients (n = 126). Regarding GI bleeding prophylaxis, only 4% (12 in 298 patients) in high care volume group did not receive treatment, whereas 26.9% of patients in low care volume group did not receive any form of treatment.

[Fig. 1](#fig1){ref-type="fig"} showed the 28-day survival curves of the ICU patients with severe sepsis between high and low care volume groups if other variables were not included in the model. The survival curve of low care volume group was lower than that of high care volume group (hazard ratio 0.709; 95% confidence interval 0.511--0.983; *p* = 0.039).Fig. 1The 28-day survival curves of ICU patients with sepsis between high and low care volume of physicians were drawn if other variables were not included in the model. The 28-day survival curve of the low care volume group is lower than that of the high care volume group. Solid and dotted lines represented the survival curve of high and low care volume of physicians, respectively (hazard ratio 0.709; 95% confidence interval 0.511--0.983; *p* = 0.039).Fig. 1

Discussion {#sec3}
==========

The present study reveals that ICU care by high care volume physicians is an independent factor lowering mortality of sepsis patients in an adult medical ICU. Although the high or low care volume physicians are all trained specialists in pulmonary and critical care medicine, a care strategy utilizing high care volume physicians seem to be better for patients with severe sepsis. Two major reasons may explain this finding.

First, high care volume physicians have a higher experience of ICU patients compared to low care volume physicians. A study reported by Durairaj et al. revealed that the risks of mortality among ICU patients with GI diagnosis or critical respiratory disease are lower in high-volume hospitals, relative to low-volume hospitals. They concluded that ICU volume was associated with mortality of patients with certain diagnoses [@bib12]. In terms of physician\'s volume, Lin et al. reported that ICU physician\'s care volume could predict the mortality of ICU patients with pneumonia [@bib10]. Their study brought out a "practice makes perfect" hypothesis, which suggested high-volume physicians had accumulated experience to manage different complicated diseases and perform more effectively in clinical practice. However, Lin\'s study has a limitation that their work is not prospective. Data in our work strongly supports this hypothesis by a prospective observational study.

Second, there are some differences in bundle therapies for sepsis between high and low care volume groups. The SSC guidelines point out that adequate initial management of sepsis and septic shock are important to improve patient outcome [@bib5]. Most initial managements for sepsis and septic shock are based on these evidence-based guidelines. There were a total of 9 therapies with observed differences in initial managements of sepsis between high and low care volume groups. Overall, high care volume physicians performed four therapies with a higher percentage of patients managed following the SSC guidelines. These four therapies were renal replacement therapy, administration of low-dose steroids for septic shock, prophylaxis of upper GI bleeding, and control of hyperglycemia. High care volume physicians performed these therapies more actively and extensively. In contrast, low care volume physicians only had one therapy that complied more with the guidelines: adequate RBC transfusion.

Townsend et al. reviewed several observational trials which suggested that better compliance of SSC guidelines might reduce mortality caused by sepsis and septic shock [@bib13], [@bib14]. The SSC had reported similar results wherein a reduction of mortality in patients with severe sepsis was associated with participation and compliance of SSC guidelines [@bib15]. This study supported that lower mortality in high care volume group may be due to better compliance to the SSC guidelines.

Regarding RBC transfusion therapy, it is noted that low care volume physicians performed more of this in the present study. Unfortunately, such better practice does not seem to lower the risk of mortality in low care volume group. Although SSC guidelines suggest adequate RBC maintenance for some specific patients with sepsis, Parsons et al. reported that RBC transfusion had no independent association with mortality in patients with sepsis and septic shock [@bib16]. A systemic review of 45 studies by Marik et al. further reported an opposite conclusion [@bib17]. In their review, RBC transfusion was associated with increased mortality in ICU patients. A more aggressive RBC transfusion also had no influence in patient mortality in this study. Thus, the effect of RBC transfusion in patients with sepsis still requires further evaluation.

This study was performed by analyzing the data of previously prospective observation, some limitations should be addressed. First, initial therapies for severe sepsis were not required to follow the SSC guidelines. All of the ICU physicians made clinical practices by their own decisions. Variations in managements for sepsis might result in different compliances to the guideline. If there was a strong consensus of the SCC guidelines for all physicians during the data collection, compliance between high and low care volume groups may not differ and affect the results. Second, only one physician was in high care volume group. Compliance to the guidelines might reflect this individual physician\'s personal compliance instead of high care volume effect. This bias in care by the single physician might also affect the results. High care volume was a concept that was opposite to low care volume. It is unclear that how many patients cared in an ICU can be considered "high enough" and how low care volume cared in physicians would affect mortality. Many issues remain uncertain and need further evaluation. Despite these limitations, the findings here still provide some suggestions of establishing an ICU care strategy of high care volume physicians.

Conclusions {#sec4}
===========

Adequate staffing of ICU physicians and an appropriate care strategy improve care quality and reduce mortality. ICU care by high care volume physicians may be better than that by low care volume physicians in patients with severe sepsis. The benefit provided by high care volume may relate to higher complete rate of bundle therapy.
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[^1]: Abbreviation: ICU: intensive care unit.

[^2]: Abbreviation: APACHE: acute physiology and chronic health evaluation.

[^3]: *p* \< 0.05 compared with fixed strategy by T-test or Chi-square test.

[^4]: Abbreviations: HR: Hazard ratio; CI: Confidence interval; CVA: cerebral vascular accident; APACHE: Acute Physiology and Chronic Health Evaluation.

[^5]: Abbreviations: APC: activated protein C; APACHE: acute physiology and chronic health evaluation; HD: hemodialysis; CVVHD: continuous veno-venous hemodialysis; GI bleeding: gastrointestinal bleeding; PPI: proton pump inhibitor; H2 blocker: histamine 2 blocker; MgO: magnesium oxide.

[^6]: Data are shown as mean.
